Additionally, for some of the original 34 patient tumor samples analyzed from Children’s Medical Center Dallas, immunohistochemistry and molecular studies were performed at the originating or referring institutions as part of the clinical diagnostic workup, which also included assessment of MYC/MYCN expression or amplification (Table S1). The gene discussed is MYCN; the disease is neoplasm.